News

CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU
Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for market authorization of ...
Camurus AB: CHMP recommends approval of Oczyesa for treatment of acromegaly in the EU
Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted ...
Scientific Research Publishing13h
Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants ()
Suzuki, R. (2025) Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants. Health, ...
The Cardiology Advisor7h
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with T2D.
Pragativadi8h
Watermelon – The Superfood of Summer
Watermelon is more than just a summer treat—it's a powerhouse of hydration, nutrients, and antioxidants. With its high water ...
Renal & Urology News8h
Canagliflozin May Improve Iron Utilization in Diabetic Nephropathy
Post hoc results support the initiation of SGLT2 inhibitors in patients with diabetic nephropathy regardless of iron deficiency. Canagliflozin treatment may improve iron markers and hemoglobin levels ...
Medscape21h
Cushing's Syndrome in Women With Polycystic Ovaries and Hyperandrogenism
1 Wessex Region Specialist Registrar in Diabetes & Endocrinology. 2 Consultant Endocrinologist at the Southampton University Hospitals NHS Trust, UK. 3 Wellcome Trust Clinician Scientist Fellow at ...